Overview: Cryptococcus Antigen (Crypto Ag) TestIntroduction: The Cryptococcus Antigen Test detects Cryptococcus antigens, indicating fungal infection causing headaches or lung issues. Aligned with 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in mycology for patients with suspected cryptococcal infections, especially in immunocompromised populations.
Other Names: Cryptococcus Antigen Assay, Fungal Antigen Test.
FDA Status: Laboratory-developed test (LDT), meeting mycology standards for diagnostic accuracy.
Historical Milestone: Cryptococcus antigen testing began in the 1980s with fungal research. Immunoassays emerged in the 1990s, and by the 2000s, high-sensitivity lateral flow assays improved diagnostic accuracy.
Purpose: Diagnoses cryptococcal infection, guides antifungal therapy, and monitors antigen levels in patients with headaches or lung issues.
Test Parameters: 1. Cryptococcus Antigen
Pretest Condition: No fasting required. Collect serum or CSF at any time. Report symptoms like headaches, fever, or cough, and list immunocompromising conditions or medications.
Specimen: 2-5 mL serum (SST) or 1-2 mL CSF (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document headaches, lung issues, or immunocompromised states (e.g., HIV, organ transplant). Include current medications, especially antifungals or immunosuppressants.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antifungal therapy.
Procedural Considerations: Uses an immunoassay (e.g., lateral flow assay) to detect Cryptococcus antigens. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Early infection or immunosuppression may reduce antigen levels. Hemolysis or improper storage can degrade samples.
Clinical Significance: Positive antigen results confirm cryptococcal infection, prompting antifungal therapy. Negative results may require PCR or culture testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A neurologist or pulmonologist referral is advised for neurological or lung involvement.
Additional Supporting Tests: Cryptococcus PCR, CSF analysis, or chest imaging to confirm infection or assess complications.
Test Limitations: False negatives may occur in early infection. Results require clinical correlation with symptoms.
References: IDSA Cryptococcus Guidelines, 2023; Clinical Infectious Diseases, Perfect JR, 2022.
